Acrophyte Hospitality Trust - DBS Research 2024-11-08: Favourable Risk-Reward At This Juncture

• Acrophyte Hospitality Trust (SGX:XZL) (fka ARA US Hospitality Trust) is the first pure-play US upscale select-service hospitality trust listed in Singapore and Asia, with its portfolio consisting of 34 Hyatt, Marriott, and Hilton-branded hotels geographically diversified across the US.
• - Read this at SGinvestors.io -

Operational metrics continue to look healthy, albeit a modest decline from a high base in 3Q23.

• - Read this at SGinvestors.io -
• Considering that travel has largely normalised and pent-up demand has eased following a strong 2023, operational metrics remain healthy, despite a slight decline.
• Since Acrophyte Hospitality Trust’s hotels are primarily domestic-focused, the decline in occupancy could be attributed to US travellers’ preferences shifting towards international travel, supported by the strength of the US$.

Sticky cost pressures weigh on margin improvements.

• Read more at SGinvestors.io.

Above is an excerpt from a report by DBS Group Research.
Clients of DBS may access the full PDF report @ https://www.dbs.com/insightsdirect/.

Read also DBS's most recent report:
2025-03-03 Acrophyte Hospitality Trust - Optimising For The Future, DPU On Growth Path.

Price targets by other brokers at Acrophyte Hospitality Trust Target Prices.

Listing of research reports at Acrophyte Hospitality Trust Analyst Reports.

Relevant links:
Acrophyte Hospitality Trust Share Price History,
Acrophyte Hospitality Trust Announcements,
Acrophyte Hospitality Trust Dividend Payout Dates & Corporate Actions,
Acrophyte Hospitality Trust News